Carroll Financial Associates’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$3K Hold
1,000
﹤0.01% 1448
2021
Q3
$4K Hold
1,000
﹤0.01% 1432
2021
Q2
$6K Hold
1,000
﹤0.01% 1406
2021
Q1
$6K Hold
1,000
﹤0.01% 1341
2020
Q4
$10K Hold
1,000
﹤0.01% 1117
2020
Q3
$3K Hold
1,000
﹤0.01% 1288
2020
Q2
$4K Hold
1,000
﹤0.01% 1249
2020
Q1
$3K Hold
1,000
﹤0.01% 1244
2019
Q4
$5K Hold
1,000
﹤0.01% 1248
2019
Q3
$5K Hold
1,000
﹤0.01% 1193
2019
Q2
$7K Hold
1,000
﹤0.01% 1119
2019
Q1
$5K Hold
1,000
﹤0.01% 1108
2018
Q4
$7K Hold
1,000
﹤0.01% 955
2018
Q3
$17K Hold
1,000
﹤0.01% 752
2018
Q2
$13K Hold
1,000
﹤0.01% 801
2018
Q1
$15K Hold
1,000
﹤0.01% 740
2017
Q4
$11K Hold
1,000
﹤0.01% 804
2017
Q3
$20K Hold
1,000
﹤0.01% 660
2017
Q2
$24K Hold
1,000
﹤0.01% 640
2017
Q1
$19K Sell
1,000
-9
-0.9% -$201 ﹤0.01% 674
2016
Q4
$24K Hold
1,009
﹤0.01% 598
2016
Q3
$28K Hold
1,009
﹤0.01% 579
2016
Q2
$24K Hold
1,009
﹤0.01% 581
2016
Q1
$33K Buy
+1,009
New +$31.8K 0.01% 503

Other funds holding PGEN

Carroll Financial Associates's PGEN Position: Q4 2021 in Review

Carroll Financial Associates held its Precigen (PGEN) position steady in Q4 2021 at 1,000 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1448.

Carroll Financial Associates first reported a position in PGEN in Q1 2016 and has held it in 24 quarters since. The position peaked at $33K in Q1 2016. 168 funds tracked by Wall St. Rank hold PGEN as of Q4 2021.

  • Carroll Financial Associates held 1,000 shares of Precigen worth $3K as of Q4 2021.
  • Carroll Financial Associates left its Precigen share count unchanged in Q4 2021.
  • Precigen made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1448 holding.
  • Carroll Financial Associates first reported a position in Precigen in Q1 2016 and has held it in 24 quarters since.
  • Carroll Financial Associates's Precigen position peaked at $33K in Q1 2016.
  • 168 funds tracked by Wall St. Rank held Precigen as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.